VDR agonist 4
VDR agonist 4 is an orally active potent VDR agonist. VDR agonist 4 exerts VDR-dependent antifibrotic activity by regulating multiple fibrosis-related genes to suppress α-SMA and collagen I production, thereby inhibiting hepatic stellate cell (HSC) activation. VDR agonist 4 improves CCl4 -induced hepatic fibrosis in mice. VDR agonist 4 can be used for liver fibrosis research[1].
Product Specifications
UNSPSC
12352005
Target
Collagen; JAK; MMP; TGF-beta/Smad; VD/VDR
Related Pathways
Cytoskeleton; Epigenetics; JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad; Vitamin D Related/Nuclear Receptor
Field of Research
Endocrinology; Metabolic Disease; Inflammation/Immunology
Smiles
CCN(C(CCCCCOC1=CC2=CC=C(C=C2C=C1)OCC3=C[C@H]([C@H]([C@@H](C3)O)O)O)=O)CC
Molecular Formula
C27H37NO6
Molecular Weight
471.59
References & Citations
[1]Gao Y, et al. Design, Synthesis, and Evaluation of Antifibrotic Activity of Nonsteroidal VDR Agonists Featuring 1,6-Naphthol as a CD-Ring Surrogate. J Med Chem. 2025 Oct 9;68 (19) :20561-20585.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR211382L3 10 µg
Eif4enif1 (NM_001166547) Mouse Tagged Lenti ORF Clone
Sign In for Pricing
View Details 
GTR15276322 1 Vial
Lentiviral mouse Uba2 shRNA (UAS) - Lentiviral mouse Uba2 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details